ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,598Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 2588

$611K Total Retail Price of All Prescriptions

Rank: 318 out of 2588

564 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 564 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 768 721 1 1
HYDROCODONE-ACETAMINOPHEN 512 419 S3 2 7
LEVOTHYROXINE SODIUM 455 432 3 2
AMLODIPINE BESYLATE 408 387 4 4
OMEPRAZOLE 398 380 5 6
FUROSEMIDE 386 356 6 5
LISINOPRIL 347 305 7 3
GLIMEPIRIDE 303 284 8 39
METFORMIN HCL 295 282 9 8
METOPROLOL SUCCINATE 289 262 10 12
METOPROLOL TARTRATE 280 265 11 9
ATORVASTATIN CALCIUM 248 226 12 11
POTASSIUM CHLORIDE 243 222 13 15
CARVEDILOL 212 208 14 20
CITALOPRAM HBR 212 186 14 27
ALLOPURINOL 186 174 16 33
PRAVASTATIN SODIUM 180 155 17 16
ALENDRONATE SODIUM 163 162 18 21
LOSARTAN POTASSIUM 154 147 19 17
ZOLPIDEM TARTRATE 148 114 20 24
HYDROCHLOROTHIAZIDE 129 121 21 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 118 22 35
CHLORTHALIDONE 120 112 23 199
ISOSORBIDE MONONITRATE ER 116 103 24 49
FAMOTIDINE 114 99 25 36
AMLODIPINE BESYLATE-BENAZEPRIL 110 108 26 76
TRIAMTERENE-HCTZ 110 102 26 46
DONEPEZIL HCL 110 110 26 22
GABAPENTIN 109 90 29 18
CLOPIDOGREL 106 87 30 30
WARFARIN SODIUM 100 99 31 10
CLONIDINE HCL 98 93 32 54
ATENOLOL 97 90 33 14
TAMSULOSIN HCL 96 96 34 23
FLUTICASONE PROPIONATE 87 72 35 40
CRESTOR 86 86 36 25
ENALAPRIL MALEATE 85 75 37 31
PLAVIX 85 72 37 43
INSULIN SYRINGE 84 59 39 81
DIOVAN 83 83 40 29
PREDNISONE 83 80 40 42
KLOR-CON M20 81 81 42 52
PEN NEEDLE 81 79 42 112
SERTRALINE HCL 80 67 44 26
PROPRANOLOL HCL 78 65 45 128
PANTOPRAZOLE SODIUM 76 70 46 28
DIGOXIN 71 71 47 38
ADVAIR DISKUS 70 70 48 48
LANTUS SOLOSTAR 66 65 49 93
DIOVAN HCT 65 63 50 72
NEXIUM 61 55 51 41
BUPROPION HCL SR 60 42 52 246
MELOXICAM 58 50 53 51
PAROXETINE HCL 57 48 54 71
FENTANYL 53 48 S2 55 78
LANTUS 53 32 55 47
SPIRONOLACTONE 52 52 57 58
GLYBURIDE-METFORMIN HCL 52 52 R 57 162
LOSARTAN-HYDROCHLOROTHIAZIDE 51 44 59 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.